Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Quantum Genomics Société Anonyme ALQGC.PA
$0.17
-$0.01 (-3.62%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
5918219.00000000
-
week52high
4.32
-
week52low
0.09
-
Revenue
116211
-
P/E TTM
0
-
Beta
0.19885400
-
EPS
-0.92000000
-
Last Dividend
0.00000000
-
Next Earnings Date
05 окт 2022 г. в 16:00
Описание компании
Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии